You clearly haven't been involved in licensing negotiations. There is a pretty large distance between LOI and executed license agreement. Synergy put out this press release not Ironwood. You have to ask, why would Ironwood accommodate a competitor? Spare me Hatch-Waxman, as companies sit on strategic IP all the time...
Synergy will not at all like the final terms they will be offered. At that point, they can swallow or infringe and litigate. IRWD is in the drivers seat.
keep making assumptions, but you clearly don't understand the nuances of a method-of-use patent in the context of hatch-waxman and the limited protection it provides in this case. You really should do your homework on this before making grand claims, but then again it only is a Yahoo! MB so no harm done.
either way good luck, this class of drug is going to be huge. IRWD should be very well and SGYP should see a nice financial windfall next year in either a lucrative partnership or an M&A deal